Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. INBIOGEN CO.,Ltd
  6. News
  7. Summary
    A101140   KR7101140002

INBIOGEN CO.,LTD

(A101140)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

INBIOGEN CO.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

11/15/2021 | 02:26am EST

INBIOGEN CO.,Ltd reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 1,666.66 million compared to KRW 2,237.96 million a year ago. Net loss was KRW 15,137.02 million compared to KRW 5,451.36 million a year ago. For the nine months, sales was KRW 4,363.23 million compared to KRW 5,073.98 million a year ago. Net loss was KRW 22,915.66 million compared to KRW 12,886.78 million a year ago.


ę S&P Capital IQ 2021
All news about INBIOGEN CO.,LTD
2021INBIOGEN CO.,Ltd announced that it has received KRW 24.0212 billion in funding from Buc..
CI
2021INBIOGEN CO.,Ltd announced that it expects to receive KRW 60.00000234 billion in fundin..
CI
2021Vidente Co., Ltd. announced that it expects to receive KRW 30.00001347 billion in fundi..
CI
2021INBIOGEN CO.,Ltd announced that it expects to receive KRW 30.00000262 billion in fundin..
CI
2021Vidente Co., Ltd. announced that it expects to receive KRW 30.00000966 billion in fundi..
CI
2021INBIOGEN CO.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended S..
CI
2021INBIOGEN CO.,Ltd announced that it has received KRW 15 billion in funding
CI
2021INBIOGEN CO.,Ltd announced that it has received KRW 23.300002 billion in funding from B..
CI
2020Vidente Co., Ltd. announced that it has received KRW 40 billion in funding from INBIOGE..
CI
2020INBIOGEN CO.,Ltd announced that it expects to receive KRW 25.00000128 billion in fundin..
CI
More news
Financials
Sales 2020 10 218 M 8,54 M 8,54 M
Net income 2020 -45 078 M -37,7 M -37,7 M
Net cash 2020 74 263 M 62,1 M 62,1 M
P/E ratio 2020 -4,81x
Yield 2020 -
Capitalization 137 B 115 M 115 M
EV / Sales 2019 9,91x
EV / Sales 2020 17,5x
Nbr of Employees 41
Free-Float 44,3%
Chart INBIOGEN CO.,LTD
Duration : Period :
INBIOGEN CO.,Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INBIOGEN CO.,LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Sang-Jun Lee Co-Chief Executive Officer & Director
Sang-Woo Kim Co-Chief Executive Officer & Director
In-Seop Oh Independent Director
Kang-Ho Kim Independent Director
Jeong-Hoon Lee Non-Executive Director